The stock of Third Harmonic Bio Inc (THRD) has seen a -18.40% decrease in the past week, with a -13.22% drop in the past month, and a -1.44% decrease in the past quarter. The volatility ratio for the week is 14.27%, and the volatility levels for the past 30 days are at 9.75% for THRD. The simple moving average for the past 20 days is -13.81% for THRD’s stock, with a -3.40% simple moving average for the past 200 days.
Is It Worth Investing in Third Harmonic Bio Inc (NASDAQ: THRD) Right Now?
Moreover, the 36-month beta value for THRD is 2.78. Analysts have varying opinions on the stock, with 4 analysts rating it as a “buy,” 2 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for THRD is 17.43M and currently, short sellers hold a 16.50% of that float. On November 21, 2024, THRD’s average trading volume was 199.09K shares.
THRD) stock’s latest price update
Third Harmonic Bio Inc (NASDAQ: THRD)’s stock price has gone decline by -6.74 in comparison to its previous close of 12.46, however, the company has experienced a -18.40% decrease in its stock price over the last five trading days. zacks.com reported 2024-11-11 that The average of price targets set by Wall Street analysts indicates a potential upside of 26.7% in Third Harmonic Bio, Inc. (THRD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Analysts’ Opinion of THRD
Many brokerage firms have already submitted their reports for THRD stocks, with Morgan Stanley repeating the rating for THRD by listing it as a “Overweight.” The predicted price for THRD in the upcoming period, according to Morgan Stanley is $20 based on the research report published on August 09, 2024 of the current year 2024.
Stifel, on the other hand, stated in their research note that they expect to see THRD reach a price target of $23. The rating they have provided for THRD stocks is “Buy” according to the report published on June 18th, 2024.
Raymond James gave a rating of “Outperform” to THRD, setting the target price at $18 in the report published on June 07th of the current year.
THRD Trading at -12.63% from the 50-Day Moving Average
After a stumble in the market that brought THRD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -31.40% of loss for the given period.
Volatility was left at 9.75%, however, over the last 30 days, the volatility rate increased by 14.27%, as shares sank -10.34% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.62% lower at present.
During the last 5 trading sessions, THRD fell by -18.40%, which changed the moving average for the period of 200-days by +26.86% in comparison to the 20-day moving average, which settled at $13.48. In addition, Third Harmonic Bio Inc saw 5.93% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at THRD starting from Conner Edward R., who sale 2,117 shares at the price of $15.00 back on Nov 08 ’24. After this action, Conner Edward R. now owns 0 shares of Third Harmonic Bio Inc, valued at $31,755 using the latest closing price.
BVF PARTNERS L P/IL, the See Explanation of Responses of Third Harmonic Bio Inc, sale 1,000,000 shares at $14.30 during a trade that took place back on Oct 29 ’24, which means that BVF PARTNERS L P/IL is holding 176,692 shares at $14,300,000 based on the most recent closing price.
Stock Fundamentals for THRD
Current profitability levels for the company are sitting at:
- -63.2 for the present operating margin
- 0.96 for the gross margin
The net margin for Third Harmonic Bio Inc stands at -13.88. The total capital return value is set at -0.18. Equity return is now at value -13.81, with -13.36 for asset returns.
Currently, EBITDA for the company is -30.79 million with net debt to EBITDA at 5.92. When we switch over and look at the enterprise to sales, we see a ratio of 276.18. The liquidity ratio also appears to be rather interesting for investors as it stands at 42.50.
Conclusion
To wrap up, the performance of Third Harmonic Bio Inc (THRD) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
